NSGl 555/l NSG555l Examl 4–l (NEWl 2026/l
2027l Update)l Nursel Practitionersl inl
Primaryl Carel IIl Review|l Questionsl &l
Answersl |l Gradel A|l 100%l Correctl
(Verifiedl Solutions)-l Wilkes
QUESTION
Whatl isl thel primaryl goall inl managingl vasculitis?
Answer:
Earlyl recognitionl tol preventl irreversiblel organl damage.
QUESTION
Whatl arel thel majorl classificationsl ofl vasculitisl basedl onl vessell size?
Answer:
Large,l medium,l orl smalll vessell vasculitis.
QUESTION
Whatl isl thel cornerstonel therapyl forl alll SLEl patients?
Answer:
Hydroxychloroquine.
QUESTION
Whatl isl thel recommendedl glucocorticoidl dosel forl moderatel tol severel disease?
Answer:
Highl dosel glucocorticoidsl -l prednisonel 1l mg/kg/day.
,QUESTION
Whatl arel commonl immunosuppressantsl usedl inl vasculitisl treatment?
Answer:
Mycophenolatel mofetil,l azathioprine,l cyclophosphamide.
QUESTION
Whatl arel thel clinicall featuresl ofl limitedl diseasel inl scleroderma?
Answer:
Skinl involvementl confinedl tol face,l neck,l andl distall extremities.
QUESTION
Whatl doesl thel acronyml CRESTl standl forl inl limitedl scleroderma?
Answer:
Calcinosis,l Raynaud'sl phenomenon,l Esophageall dysmotility,l Sclerodactyly,l Telangiectasias.
QUESTION
Whatl isl thel significancel ofl temporall arteryl biopsyl inl vasculitis?
Answer:
Essentiall forl diagnosingl suspectedl giantl celll arteritis.
QUESTION
Whatl arel thel generall symptomsl ofl vasculitis?
Answer:
Fever,l weightl loss,l fatigue,l malaise,l myalgias,l andl arthralgias.
,QUESTION
Whatl isl thel goldl standardl forl diagnosingl vasculitis?
Answer:
Biopsyl tol confirml vessell walll inflammation.
QUESTION
Whatl isl thel initiall diagnosticl testl forl assessingl kidneyl involvementl inl vasculitis?
Answer:
Renall panell andl urinalysis.
QUESTION
Whatl isl thel first-linel treatmentl forl renall crisisl inl scleroderma?
Answer:
ACEl inhibitors.
QUESTION
Whatl arel commonl skinl findingsl inl smalll vessell vasculitis?
Answer:
Purpura,l vesiculobullousl lesions,l urticaria.
QUESTION
Whatl laboratoryl testsl arel elevatedl inl activel vasculitis?
Answer:
ESRl &l CRP.
QUESTION
Whatl arel thel commonl organl involvementsl inl diffusel cutaneousl scleroderma?
, Answer:
Lungs,l kidneys,l andl GIl tract.
QUESTION
Whatl isl thel typicall agel rangel forl thel onsetl ofl systemicl sclerosisl symptoms?
Answer:
Thirdl tol fifthl decadesl ofl life.
QUESTION
Whatl isl thel rolel ofl ANCAl testingl inl vasculitis?
Answer:
Tol helpl classifyl thel subtypel ofl vasculitis.
QUESTION
Whatl arel thel commonl pulmonaryl findingsl inl vasculitis?
Answer:
Hemoptysis,l dyspnea,l andl infiltrates.
QUESTION
Whatl isl thel prognosisl forl patientsl withl limitedl cutaneousl systemicl sclerosis?
Answer:
Betterl overalll withl slowerl progression.
QUESTION
Whatl isl thel commonl demographicl characteristicl ofl systemicl sclerosis?
Answer:
2027l Update)l Nursel Practitionersl inl
Primaryl Carel IIl Review|l Questionsl &l
Answersl |l Gradel A|l 100%l Correctl
(Verifiedl Solutions)-l Wilkes
QUESTION
Whatl isl thel primaryl goall inl managingl vasculitis?
Answer:
Earlyl recognitionl tol preventl irreversiblel organl damage.
QUESTION
Whatl arel thel majorl classificationsl ofl vasculitisl basedl onl vessell size?
Answer:
Large,l medium,l orl smalll vessell vasculitis.
QUESTION
Whatl isl thel cornerstonel therapyl forl alll SLEl patients?
Answer:
Hydroxychloroquine.
QUESTION
Whatl isl thel recommendedl glucocorticoidl dosel forl moderatel tol severel disease?
Answer:
Highl dosel glucocorticoidsl -l prednisonel 1l mg/kg/day.
,QUESTION
Whatl arel commonl immunosuppressantsl usedl inl vasculitisl treatment?
Answer:
Mycophenolatel mofetil,l azathioprine,l cyclophosphamide.
QUESTION
Whatl arel thel clinicall featuresl ofl limitedl diseasel inl scleroderma?
Answer:
Skinl involvementl confinedl tol face,l neck,l andl distall extremities.
QUESTION
Whatl doesl thel acronyml CRESTl standl forl inl limitedl scleroderma?
Answer:
Calcinosis,l Raynaud'sl phenomenon,l Esophageall dysmotility,l Sclerodactyly,l Telangiectasias.
QUESTION
Whatl isl thel significancel ofl temporall arteryl biopsyl inl vasculitis?
Answer:
Essentiall forl diagnosingl suspectedl giantl celll arteritis.
QUESTION
Whatl arel thel generall symptomsl ofl vasculitis?
Answer:
Fever,l weightl loss,l fatigue,l malaise,l myalgias,l andl arthralgias.
,QUESTION
Whatl isl thel goldl standardl forl diagnosingl vasculitis?
Answer:
Biopsyl tol confirml vessell walll inflammation.
QUESTION
Whatl isl thel initiall diagnosticl testl forl assessingl kidneyl involvementl inl vasculitis?
Answer:
Renall panell andl urinalysis.
QUESTION
Whatl isl thel first-linel treatmentl forl renall crisisl inl scleroderma?
Answer:
ACEl inhibitors.
QUESTION
Whatl arel commonl skinl findingsl inl smalll vessell vasculitis?
Answer:
Purpura,l vesiculobullousl lesions,l urticaria.
QUESTION
Whatl laboratoryl testsl arel elevatedl inl activel vasculitis?
Answer:
ESRl &l CRP.
QUESTION
Whatl arel thel commonl organl involvementsl inl diffusel cutaneousl scleroderma?
, Answer:
Lungs,l kidneys,l andl GIl tract.
QUESTION
Whatl isl thel typicall agel rangel forl thel onsetl ofl systemicl sclerosisl symptoms?
Answer:
Thirdl tol fifthl decadesl ofl life.
QUESTION
Whatl isl thel rolel ofl ANCAl testingl inl vasculitis?
Answer:
Tol helpl classifyl thel subtypel ofl vasculitis.
QUESTION
Whatl arel thel commonl pulmonaryl findingsl inl vasculitis?
Answer:
Hemoptysis,l dyspnea,l andl infiltrates.
QUESTION
Whatl isl thel prognosisl forl patientsl withl limitedl cutaneousl systemicl sclerosis?
Answer:
Betterl overalll withl slowerl progression.
QUESTION
Whatl isl thel commonl demographicl characteristicl ofl systemicl sclerosis?
Answer:
